NovaBridge Biosciences (NBP) Deferred Taxes (2020)

NovaBridge Biosciences (NBP) posted quarterly Deferred Taxes of -$19465.2 for Q4 2020, down 10.43% on a QoQ basis from -$17626.4 in Q3 2020.

NovaBridge Biosciences (NBP) Deferred Taxes (2020) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Deferred Taxes for 1 consecutive years, with -$19465.2 the latest figure, recorded in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 NovaBridge Biosciences 389.86 Mn 389.86 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -19,465.24
Sep 30, 2020 -17,626.44